Ironwood Investment Counsel, LLC Renalytix PLC Transaction History
Ironwood Investment Counsel, LLC
- $554 Million
- Q4 2024
A detailed history of Ironwood Investment Counsel, LLC transactions in Renalytix PLC stock. As of the latest transaction made, Ironwood Investment Counsel, LLC holds 10,000 shares of RNLX stock, worth $1,500. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,000
Previous 12,000
16.67%
Holding current value
$1,500
Previous $2,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding RNLX
# of Institutions
18Shares Held
2.3MCall Options Held
13.7KPut Options Held
0-
Pinnacle Associates LTD847KShares$126,9800.0% of portfolio
-
Stifel Financial Corp St. Louis, MO489KShares$73,4140.0% of portfolio
-
Ubs Group Ag280KShares$41,9610.0% of portfolio
-
Gofen & Glossberg LLC188KShares$28,2330.01% of portfolio
-
Parian Global Management LP Pound Ridge, NY185KShares$27,7190.77% of portfolio
About Renalytix plc
- Ticker RNLX
- Exchange OTC
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 37,445,900
- Market Cap $5.62M
- Description
- Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics and personalized patient data ...